Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.32 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11349778 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CHRM2CHRM5CHRM1CHRM4 | |
| SCHEMBL11270777 | 0.89 | ALDH1A1 (0.43) | ALDH1A1CHRM2CHRM5CHRM1CHRM4 | |
| SCHEMBL664256 | 0.85 | — | — | |
| SCHEMBL5694697 | 0.82 | ALDH1A1 (0.43) | ALDH1A1EPHX1KDM4ESPHK1SPHK2 | |
| SCHEMBL7511568 | 0.79 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRMAPK1TDP1 | |
| SCHEMBL7517505 | 0.79 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRMAPK1TDP1 | |
| SCHEMBL5340594 | 0.79 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRMAPK1TDP1 | |
| SCHEMBL33715 | 0.79 | ALDH1A1 (0.68) | ALDH1A1EPHX1TSHRMAPK1TDP1 | |
| SCHEMBL7540476 | 0.76 | ALDH1A1 (0.74) | ALDH1A1EPHX1TSHRSPHK1SPHK2 | |
| SCHEMBL13865560 | 0.76 | ALDH1A1 (0.74) | ALDH1A1EPHX1TSHRSPHK1SPHK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1979336-B1 | PROCESS FOR PRODUCING OF EPOXY COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-20090054670-A1 | Process for Producing of Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054670-A1 | Process for Producing of Epoxy Compound | SQLE, SQOR, HMOX2 | ALDH1A1 2376/4885CHRM2 2471/4885CHRM5 2820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.